Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 43; no. 12; pp. 2855 - 2861
Main Authors MCDOWELL, J. A, CHITTICK, G. E, RAVITCH, J. R, POLK, R. E, KERKERING, T. M, STEIN, D. S
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.12.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Corresponding author. Mailing address: Worldwide Clinical Pharmacology, Glaxo Wellcome, Inc., Five Moore Dr., Research Triangle Park, NC 27709. Phone: (919) 483-1102. Fax: (919) 483-6380. E-mail: JAM36914@glaxowellcome.com.
ISSN:0066-4804
1098-6596
DOI:10.1128/aac.43.12.2855